Pulmonology–Rheumatology 2026
Collaboration in Interstitial Lung Disease From Mechanistic Pathways To Clinical Management
IN-PERSON & VIRTUAL CONFERENCE
NOTE: In-person registration includes light breakfast and lunch
Program Description
This comprehensive, full-day symposium brings together leading experts in pulmonology, rheumatology, radiology, and translational science to advance the understanding and management of interstitial lung diseases (ILDs) associated with systemic autoimmune conditions. Through state-of-the-art lectures, case-based discussions, and emerging research highlights, participants will explore the latest advances in disease mechanisms, diagnostic strategies, imaging interpretation, biomarker development, and therapeutic innovation. Special emphasis will be placed on connective tissue disease–associated ILD, including sarcoidosis, systemic sclerosis, rheumatoid arthritis, myositis, and fibrosing phenotypes, as well as ILD-related pulmonary hypertension and considerations for lung transplantation. The program is designed to promote multidisciplinary collaboration and equip clinicians with practical, evidence-based tools to enhance patient care.
Target Audience Statement
This program is designed for pulmonologists, rheumatologists, radiologists, transplant specialists, primary care physicians, nurse practitioners, physician assistants, fellows, residents, nurses, and other healthcare professionals involved in the diagnosis, management, or research of interstitial lung diseases and systemic autoimmune conditions. The symposium will also benefit clinicians seeking to enhance their understanding of complex ILD presentations, apply current guideline-based practices, and integrate emerging diagnostic technologies and therapies into clinical care.
Video Access
Following the program, all registrants will have access to lecture video recordings for ONE month.
